The top 10 biopharma stock gainers and losers for the week.

These graphs compare the performance of the biotech stocks for all of 2026 using the BioWorld Stock Indicator and the Nasdaq Biotech Index.

Year-to-date money raised in public, private and other financings of biopharma companies.

Total raised in public, private and other financings of biopharma companies, comparing 2019-2026.

Biopharma money raised to-date and by month in 2026, including public, private and other financings.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: A2 Biotherapeutics, Abbisko, Baebies, Bioxcel, Chiesi, Cogent, Orca, Ray, Restore Robotics, Serenity, Vertex.

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Amgen, BMS, Briacell, Briapro, Daiichi, Frontier, IO Biotech, Iterum, Janux, LG Chem, Maat, Merit Medical, Nuvation, Oncolytics, View Point, Zai Lab.

Clinical updates for biopharma and med tech, including data readouts and publications: Anixa, Bambusa, Biotronik, Braveheart, Bridgebio, Caris, Corvista, Edwards, Electrocore, Enveda, Gan & Lee, Hengrui, Hoth, Maia, Tonix.

Biopharma and med-tech companies raising money in public or private financings, including: Apollomics, Aprea, Bonus, Fibrobiologics, Innocan, Inspira, Newcelx, Venus Concept.

New hires and promotions in the biopharma and med-tech industries, including: Aavantgarde, Airos, Alloy, Ardelyx, Bayer, Bruker, Corwave, Evotec, Expres2ion, Femasys, Mosaic, Nanoscope, Nocion, Orionis and Zymeworks.